Press Releases

Press Releases

UL (Underwriters Laboratories), a premier safety science company, has been successfully audited and accredited for testing portable cells and batteries by the Bureau of Indian Standards (BIS). Expertise from the global UL team helped UL in Bangalore meet the requirements of Indian standard IS16046 and requirements of CRO accreditation by…

Press Releases

Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial infarction, stent thrombosis, and stroke because of insufficient clopidogrel-induced platelet inhibition. Using customized relational…

Press Releases

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for idarucizumab, which is being investigated to specifically reverse the anticoagulant effect of dabigatran, the active ingredient in Pradaxa® (dabigatran etexilate mesylate) in patients needing emergency…

Press Releases

The mesothelioma law firm of Baron & Budd reports the U.S. Food and Drug Administration has granted orphan drug administration to CRS-207, an immunotherapy vaccine that could greatly impact treatment for malignant pleural mesothelioma. The designation was granted on March 26 to CRS-207 manufacturer Aduro Biotech, Inc. In May 2014,…

Press Releases

OWC Pharmaceutical Research Corp., developer of cannabinoid-based therapies and consulting services to governments, today announced that its wholly owned subsidiary, One World Cannabis Ltd. ("the Company"), has entered into agreement with G.C. Group to develop new formulations and delivery methods targeting several medical indications. Under the terms of the agreement,…

Press Releases

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced the start of a clinical phase II study to evaluate Debio 1450 for the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) due to Staphylococci, including all resistant Staphylococcus strains, tested so far.…

Press Releases

Mylan N.V. today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched generic Sofosbuvir 400 mg tablets under the brand name MyHep™ in India. The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing…

Press Releases

After the success of our inaugural event, Oxford Global Conferences are proud to announce the 2nd Annual Microbiology & Infectious Diseases Asia Congress will be taking place on the 23rd & 24th June 2015 in Singapore. Consisting of over 40 presentations across four interactive streams, the event is a unique…

Press Releases

Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration. The goal of the collaboration is to advance a portfolio consisting of programs with novel mechanisms of action targeting immune checkpoint pathways, co-stimulatory signals and regulatory…

Press Releases

Oxford Global Conferences are thrilled to announce that registration has now opened for the 5th Annual Next Generation Sequencing Asia Congress and co-located 3rd Annual Single Cell Analysis Asia Congress. Taking place on the 13th & 14th October 2015 in Singapore, the conference will provide over 175 international NGS and…